Stanley Frankel

Company: Cytovia Therapeutics

Job title: CMO

Seminars:

iPSC-Derived NK cell (iNK) Iterations and NK Engagers to Target and Kill Solid Tumors 4:00 pm

• Potential of iNK as therapeutics • Potential role and synergy of NKp46 engagementRead more

day: Day Two